Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Condition(s):Langerhans Cell HistiocytosisLast Updated:August 28, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Langerhans Cell HistiocytosisLast Updated:August 28, 2023Recruiting
Condition(s):Relapsed Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Minimal Residual DiseaseLast Updated:May 5, 2022Not yet recruiting
Condition(s):Acute Myeloid Leukemia; Core-Binding FactorLast Updated:May 11, 2022Recruiting
Condition(s):Relapsed or Refractory Acute Myeloid Leukemia (AML)Last Updated:May 6, 2023Recruiting
Condition(s):AMLLast Updated:October 5, 2023Recruiting
Condition(s):High-risk (Secondary) Acute Myeloid LeukemiaLast Updated:December 28, 2023Not yet recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromesLast Updated:March 5, 2024Not yet recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:September 21, 2023Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:April 7, 2023Recruiting
Condition(s):Leukemia, Myeloid, AcuteLast Updated:November 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.